Skip to main content

Compare Stocks

Date Range: 

 LeMaitre VascularTactile Systems TechnologyCerusSI-BONEOrthoPediatrics
SymbolNASDAQ:LMATNASDAQ:TCMDNASDAQ:CERSNASDAQ:SIBNNASDAQ:KIDS
Price Information
Current Price$49.19$54.51$5.75$31.96$56.00
52 Week RangeHoldBuyBuyBuyBuy
MarketRank™
Overall Score1.91.21.71.51.5
Analysis Score1.21.33.52.52.5
Community Score2.92.82.92.52.5
Dividend Score1.70.00.00.00.0
Ownership Score1.70.01.71.71.7
Earnings & Valuation Score1.91.90.60.60.6
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$47.80$59.00$8.50$38.43$64.71
% Upside from Price Target-2.83% downside8.24% upside47.83% upside20.24% upside15.56% upside
Trade Information
Market Cap$1.01 billion$1.07 billion$984.24 million$1.05 billion$1.10 billion
Beta1.431.691.371.410.67
Average Volume125,640157,8052,144,572285,075192,655
Sales & Book Value
Annual Revenue$117.23 million$189.49 million$74.65 million$67.30 million$72.55 million
Price / Sales8.655.6513.1815.5815.17
Cashflow$1.38 per share$0.80 per shareN/AN/AN/A
Price / Cash35.6268.21N/AN/AN/A
Book Value$7.41 per share$5.92 per share$0.41 per share$2.52 per share$8.51 per share
Price / Book6.649.2114.0212.686.58
Profitability
Net Income$17.93 million$10.97 million$-71,240,000.00$-38,400,000.00$-13,730,000.00
EPS$0.88$0.56($0.51)($1.55)($0.87)
Trailing P/E Ratio52.89N/AN/AN/AN/A
Forward P/E Ratio41.69165.18N/AN/AN/A
P/E Growth3.5210.36N/AN/AN/A
Net Margins15.41%-4.57%-73.72%-61.67%-34.26%
Return on Equity (ROE)12.32%1.37%-63.47%-45.03%-11.57%
Return on Assets (ROA)8.45%0.99%-30.82%-29.29%-8.79%
Dividend
Annual Payout$0.44N/AN/AN/AN/A
Dividend Yield0.89%N/AN/AN/AN/A
Three-Year Dividend Growth72.73%N/AN/AN/AN/A
Payout Ratio50.00%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.23%N/A0.36%0.39%N/A
Current Ratio2.30%4.45%3.84%12.65%6.27%
Quick Ratio1.27%3.58%3.42%12.22%4.25%
Ownership Information
Institutional Ownership Percentage84.17%N/A82.06%65.26%71.74%
Insider Ownership Percentage16.50%5.30%6.49%15.50%33.60%
Miscellaneous
Employees386707254295116
Shares Outstanding20.61 million19.65 million171.17 million32.81 million19.66 million
Next Earnings Date7/22/2021 (Estimated)8/2/2021 (Estimated)8/3/2021 (Estimated)8/2/2021 (Estimated)8/4/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
SourceHeadline
Pediatric Orthopedic Implants Market to Witness Huge Growth by 2027 | OrthoPediatrics, WishBone Medical, Arthrex – Test & Measurement - Test & MeasurementPediatric Orthopedic Implants Market to Witness Huge Growth by 2027 | OrthoPediatrics, WishBone Medical, Arthrex – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 13 at 9:11 AM
 Analysts Anticipate OrthoPediatrics Corp. (NASDAQ:KIDS) to Announce -$0.35 EPS Analysts Anticipate OrthoPediatrics Corp. (NASDAQ:KIDS) to Announce -$0.35 EPS
americanbankingnews.com - May 11 at 5:18 PM
OrthoPediatrics (KIDS) CEO Mark Throdahl on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaOrthoPediatrics' (KIDS) CEO Mark Throdahl on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 9 at 9:39 AM
OrthoPediatrics Corp. (NASDAQ:KIDS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$67.00 - NasdaqOrthoPediatrics Corp. (NASDAQ:KIDS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$67.00 - Nasdaq
nasdaq.com - May 8 at 1:28 PM
OrthoPediatrics (NASDAQ:KIDS) PT Raised to $72.00OrthoPediatrics (NASDAQ:KIDS) PT Raised to $72.00
americanbankingnews.com - May 7 at 4:08 PM
OrthoPediatrics (NASDAQ:KIDS) Price Target Increased to $72.00 by Analysts at Truist SecuritiesOrthoPediatrics (NASDAQ:KIDS) Price Target Increased to $72.00 by Analysts at Truist Securities
marketbeat.com - May 7 at 3:10 PM
OrthoPediatrics (KIDS) Moves 9.1% Higher: Will This Strength Last?OrthoPediatrics (KIDS) Moves 9.1% Higher: Will This Strength Last?
finance.yahoo.com - May 7 at 2:49 PM
OrthoPediatrics (NASDAQ:KIDS) PT Raised to $70.00OrthoPediatrics (NASDAQ:KIDS) PT Raised to $70.00
americanbankingnews.com - May 7 at 12:58 PM
OrthoPediatrics (KIDS) Moves 9.1% Higher: Will This Strength Last? - NasdaqOrthoPediatrics (KIDS) Moves 9.1% Higher: Will This Strength Last? - Nasdaq
nasdaq.com - May 7 at 9:48 AM
OrthoPediatrics Corp. Reports First Quarter 2021 Financial Results - Yahoo FinanceOrthoPediatrics Corp. Reports First Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - May 7 at 4:48 AM
OrthoPediatrics Corp. (KIDS) PT Raised to $72 at Truist Securities Following Earnings - StreetInsider.comOrthoPediatrics Corp. (KIDS) PT Raised to $72 at Truist Securities Following Earnings - StreetInsider.com
streetinsider.com - May 6 at 6:47 PM
OrthoPediatrics Quarterly Loss Widens - Inside INdiana BusinessOrthoPediatrics Quarterly Loss Widens - Inside INdiana Business
insideindianabusiness.com - May 6 at 6:47 PM
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Consensus Rating of "Buy" by BrokeragesOrthoPediatrics Corp. (NASDAQ:KIDS) Given Consensus Rating of "Buy" by Brokerages
americanbankingnews.com - May 6 at 6:10 PM
OrthoPediatrics (NASDAQ:KIDS) Receives "Overweight" Rating from Piper SandlerOrthoPediatrics (NASDAQ:KIDS) Receives "Overweight" Rating from Piper Sandler
americanbankingnews.com - May 6 at 5:04 PM
Bernie B. Berry III Sells 3,209 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) StockBernie B. Berry III Sells 3,209 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) Stock
americanbankingnews.com - May 6 at 2:48 PM
What is the Markets View on Orthopediatrics Corp (KIDS) Stocks Price and Volume Trends Thursday? - InvestorsObserverWhat is the Market's View on Orthopediatrics Corp (KIDS) Stock's Price and Volume Trends Thursday? - InvestorsObserver
investorsobserver.com - May 6 at 1:46 PM
Analysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS), OrthoPediatrics (KIDS) and Diamedica Therapeutics (DMAC) - Smarter AnalystAnalysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS), OrthoPediatrics (KIDS) and Diamedica Therapeutics (DMAC) - Smarter Analyst
smarteranalyst.com - May 6 at 1:46 PM
OrthoPediatrics ticks up on Street-beating Q1 results - Mass DeviceOrthoPediatrics ticks up on Street-beating Q1 results - Mass Device
massdevice.com - May 6 at 1:46 PM
OrthoPediatrics (NASDAQ:KIDS) Reaches New 52-Week High at $61.84OrthoPediatrics (NASDAQ:KIDS) Reaches New 52-Week High at $61.84
americanbankingnews.com - May 6 at 12:44 PM
OrthoPediatrics (NASDAQ:KIDS) Releases FY 2021 Earnings GuidanceOrthoPediatrics (NASDAQ:KIDS) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 5 at 11:58 PM
OrthoPediatrics: Q1 Earnings Snapshot - Journal ReviewOrthoPediatrics: Q1 Earnings Snapshot - Journal Review
journalreview.com - May 5 at 10:45 PM
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo FinanceOrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 5 at 10:45 PM
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue EstimatesOrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 5 at 10:45 PM
OrthoPediatrics EPS in-line, beats on revenue - Seeking AlphaOrthoPediatrics EPS in-line, beats on revenue - Seeking Alpha
seekingalpha.com - May 5 at 5:45 PM
ORTHOPEDIATRICS CORP : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - marketscreener.comORTHOPEDIATRICS CORP : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - marketscreener.com
marketscreener.com - May 5 at 5:45 PM
OrthoPediatrics Corp. Reports First Quarter 2021 Financial Results - GlobeNewswireOrthoPediatrics Corp. Reports First Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - May 5 at 5:45 PM
DateCompanyBrokerageAction
5/10/2021LeMaitre VascularRoth CapitalBoost Price Target
4/30/2021LeMaitre VascularLake Street CapitalBoost Price Target
4/30/2021LeMaitre VascularBarrington ResearchBoost Price Target
2/12/2021LeMaitre VascularKeyCorpInitiated Coverage
7/24/2020LeMaitre VascularStifel NicolausBoost Price Target
7/24/2020LeMaitre VascularCanaccord GenuityBoost Price Target
4/8/2020LeMaitre VascularSidotiLower Price Target
10/24/2019LeMaitre VascularFirst AnalysisDowngrade
1/25/2021Tactile Systems TechnologyBTIG ResearchBoost Price Target
11/13/2020Tactile Systems TechnologyOppenheimerUpgrade
4/6/2020Tactile Systems TechnologyPiper SandlerReiterated Rating
11/18/2019Tactile Systems TechnologyPiper Jaffray CompaniesInitiated Coverage
6/13/2019Tactile Systems TechnologyDougherty & CoInitiated Coverage
5/7/2019Tactile Systems TechnologyGuggenheimBoost Price Target
3/22/2019Tactile Systems TechnologyNorthland SecuritiesReiterated Rating
6/15/2020CerusCantor FitzgeraldInitiated Coverage
4/16/2020CerusStephensLower Price Target
8/3/2018CerusCowenSet Price Target
5/10/2021SI-BONENeedham & Company LLCBoost Price Target
5/10/2021SI-BONEMorgan StanleyBoost Price Target
5/4/2021SI-BONETruist SecuritiesBoost Price Target
1/8/2021SI-BONEJMP SecuritiesBoost Price Target
1/7/2020OrthoPediatricsSunTrust BanksInitiated Coverage
(Data available from 5/16/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.